Related references
Note: Only part of the references are listed.Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study
Adrian J. C. Bloor et al.
NATURE MEDICINE (2020)
Mitochondria in Sepsis-Induced AKI
Jian Sun et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Mesenchymal stem cells prevent the progression of diabetic nephropathy by improving mitochondrial function in tubular epithelial cells
Seung Eun Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
VEGF and FGF-2: Promising targets for the treatment of respiratory disorders
Ankit P. Laddha et al.
RESPIRATORY MEDICINE (2019)
Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathways
Xiaoting Liang et al.
FASEB JOURNAL (2019)
Kidney-Immune System Crosstalk in AKI
Kai Singbartl et al.
SEMINARS IN NEPHROLOGY (2019)
Protective effect of bone marrow mesenchymal stem cells modified with klotho on renal ischemia-reperfusion injury
Li-Bo Xie et al.
RENAL FAILURE (2019)
Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery
Madhav Swaminathan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
A review of the role of immune cells in acute kidney injury
Anthony Bonavia et al.
PEDIATRIC NEPHROLOGY (2018)
Enhanced proliferation and differentiation of HO-1 gene-modified bone marrow-derived mesenchymal stem cells in the acute injured kidney
Nanmei Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Paradigms of acute kidney injury in the intensive care setting
John A. Kellum et al.
NATURE REVIEWS NEPHROLOGY (2018)
Klotho gene-modified BMSCs showed elevated antifibrotic effects by inhibiting the Wnt/β-catenin pathway in kidneys after acute injury
Feng Zhang et al.
CELL BIOLOGY INTERNATIONAL (2018)
VEGF therapy for the kidney: emerging strategies
Erika Guise et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Michael F. Naso et al.
BIODRUGS (2017)
Heme Oxygenase 1 as a Therapeutic Target in Acute Kidney Injury
Subhashini Bolisetty et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps
Hamid Rabb et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Mitochondria: a therapeutic target in acute kidney injury
Yu Ishimoto et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Jacques Galipeau et al.
CYTOTHERAPY (2016)
Cellular and Molecular Mechanisms of AKI
Anupam Agarwal et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence
Anna Julie Peired et al.
STEM CELLS INTERNATIONAL (2016)
Alleviation of apoptosis of bone marrow-derived mesenchymal stem cells in the acute injured kidney by heme oxygenase-1 gene modification
Nanmei Liu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
CXCR4 Receptor Overexpression in Mesenchymal Stem Cells Facilitates Treatment of Acute Lung Injury in Rats
Jing-Xian Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Adenovirus-Mediated Over-Expression of Nrf2 Within Mesenchymal Stem Cells (MSCs) Protected Rats Against Acute Kidney Injury
Mohammad Mohammadzadeh-Vardin et al.
ADVANCED PHARMACEUTICAL BULLETIN (2015)
Aging Mesenchymal Stem Cells Fail to Protect Because of Impaired Migration and Antiinflammatory Response
Martha L. Bustos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages
Yanqiu Geng et al.
STEM CELL RESEARCH & THERAPY (2014)
Genetic engineering of mesenchymal stem cells by non-viral gene delivery
Weiwei Wang et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2014)
Regulatory T Cells in AKI
Gilbert R. Kinsey et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions
Jie Hu et al.
KIDNEY INTERNATIONAL (2013)
Hypoxic Preconditioning with Cobalt of Bone Marrow Mesenchymal Stem Cells Improves Cell Migration and Enhances Therapy for Treatment of Ischemic Acute Kidney Injury
Xiaofang Yu et al.
PLOS ONE (2013)
Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them
Sangeetha Hareendran et al.
REVIEWS IN MEDICAL VIROLOGY (2013)
Enhancing the Migration Ability of Mesenchymal Stromal Cells by Targeting the SDF-1/CXCR4 Axis
Leah A. Marquez-Curtis et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Perspective and challenges of mesenchymal stem cells for cardiovascular regeneration
Yuelin Zhang et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2013)
CXCR4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injury
Nanmei Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Regulation of cell proliferation of human induced pluripotent stem cell-derived mesenchymal stem cells via ether-a-go-go 1 (hEAG1) potassium channel
Jiao Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Klotho as a potential biomarker and therapy for acute kidney injury
Ming-Chang Hu et al.
NATURE REVIEWS NEPHROLOGY (2012)
Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling
Minoru Satoh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Non-Viral Gene Delivery to Mesenchymal Stem Cells: Methods, Strategies and Application in Bone Tissue Engineering and Regeneration
Jose L. Santos et al.
CURRENT GENE THERAPY (2011)
Protein Expression of Mesenchymal Stem Cells after Transfection of pcDNA3.1--hVEGF165 by Ultrasound-Targeted Microbubble Destruction
Zhaoxia Pu et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Erythropoietin Gene-enhanced Marrow Mesenchymal Stromal Cells Decrease Cisplatin-induced Kidney Injury and Improve Survival of Allogeneic Mice
Nicoletta Eliopoulos et al.
MOLECULAR THERAPY (2011)
Hepatocyte Growth Factor Modification Promotes the Amelioration Effects of Human Umbilical Cord Mesenchymal Stem Cells on Rat Acute Kidney Injury
Yuan Chen et al.
STEM CELLS AND DEVELOPMENT (2011)
VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury
Li Yuan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery
Christopher D. Porada et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Mesenchymal stem cells at the intersection of cell and gene therapy
Timothy J. Myers et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Progress and prospects: immune responses to viral vectors
S. Nayak et al.
GENE THERAPY (2010)
Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway
Jie Yu Ye et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Mesenchymal stem cells: a new therapeutic tool for AKI
Florian E. Toegel et al.
NATURE REVIEWS NEPHROLOGY (2010)
Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70
Hidekazu Sugiura et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Heme oxygenase and renal disease
Tambi Jarmi et al.
CURRENT HYPERTENSION REPORTS (2009)
Optimizing mesenchymal stem cell-based therapeutics
Joseph Wagner et al.
CURRENT OPINION IN BIOTECHNOLOGY (2009)
Analysis of changes in the viability and gene expression profiles of human mesenchymal stromal cells over time
Kyoung A. Lee et al.
CYTOTHERAPY (2009)
Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells
Ekaterina Ivanova-Todorova et al.
IMMUNOLOGY LETTERS (2009)
Early modulation of inflammation by mesenchymal stem cell after acute kidney injury
Patricia Semedo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury
Florian Toegel et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury
Stefania Bruno et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Autologous and Allogeneic Marrow Stromal Cells Are Safe and Effective for the Treatment of Acute Kidney Injury
Florian Toegel et al.
STEM CELLS AND DEVELOPMENT (2009)
Genetic deficiency in tissue kallinkrein activity in mouse and man: effect on arteries, heart and kidney
Anne Pizard et al.
BIOLOGICAL CHEMISTRY (2008)
Immunity to adeno-associated virus vectors in animals and humans: a continued challenge
A. K. Zaiss et al.
GENE THERAPY (2008)
Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation
Makoto Hagiwara et al.
HUMAN GENE THERAPY (2008)
Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice
Marina Morigi et al.
STEM CELLS (2008)
Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells
Ivana Rosova et al.
STEM CELLS (2008)
Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury
M. B. Herrera et al.
KIDNEY INTERNATIONAL (2007)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Nrf2 controls bone marrow stromal cell susceptibility to oxidative and electrophilic stress
Hong Zhu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure
D. W. Johnson et al.
KIDNEY INTERNATIONAL (2006)
Epidemiology and outcomes of acute renal failure in hospitalized patients: A national survey
Orfeas Liangos et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms
F Tögel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
New avenues of exploration for erythropoietin
K Maiese et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress
JJ Zhang et al.
KIDNEY INTERNATIONAL (2004)
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
K Jooss et al.
GENE THERAPY (2003)
Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector
H Tsuda et al.
MOLECULAR THERAPY (2003)
Unexpected renal actions of erythropoietin
C Westenfelder
EXPERIMENTAL NEPHROLOGY (2002)
Prediction and optimization of gene transfection and drug delivery by electroporation
PJ Canatella et al.
GENE THERAPY (2001)
Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases
K Matsumoto et al.
KIDNEY INTERNATIONAL (2001)
Hepatocyte growth factor in renal failure: Promise and reality
GA Vargas et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
